IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
Life review of elderly depression
Development and application of ATR-FTIR spectroscopy for mixture homogeneity in pharmaceutical application
The Increasing Damage in Tubular Cell of Infant Mice’s Kidneys from Carbofuran Exposure during its Mothers’ Lactation Period
Trend of transsexualism problem and its implications towards muslim community in Malaysia
Development and validation of RP-HPLC method for the estimation of pidotimod in tablet dosage form
Evaluation of neurotoxicity of the ethanolic bark extract of Holarrhena pubescens Wall. ex G.Don in mice
Design, synthesis and evaluation of 2-aminobenzimidazole derivatives: strong candidate for PPAR gamma agonists.
Prediction of Heart Disease Using Feature Selection and Random Forest Ensemble Method
Strategies for Antiviral Drugs from Plants by Targeting the Hemagglutinin, Neuraminidase and other receptors of Influenza A virus
The impact of human resource and quality management in health care: A Review
12345678910...
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
IN-VITRO CHARACTERIZATION AND AEROSOL DISPERSION PERFORMANCE OF TERBUTALINE SULPHATE AND ITRACONAZOLE NANOPARTICLES AS DRY POWDER INSUFFLATION FOR THE TREATMENT OF ASTHMA PREPARED BY PHYSICAL MIXING AND SPRAY DRYING

Author: VENUGOPALAIAH.PENABAKA , B.KUMAR, N.B.L.PRASAD
Abstract: The objective of the present work was to check an Aerosol Dispersion Performance of Terbutaline Sulphate and Itraconazole Nanoparticles as Dry Powder Insufflation for the treatment of Asthma. Dry powder nanoparticles of Terbutaline Sulphate and Itraconazole were aimed to develop using lactose and trehalose as carriers by physical mixing and spray drying. In this work spray dried nanoparticles containing Terbutaline Sulphate, Itraconazole and combination of both was rationally designed via organic solution advanced spray drying (no water) in closed mode from dilute feed concentration. It was observed that Scanning electron microscopy showed smooth and nearly spherical particles for spray dried formulations whereas formulations prepared through milling were found to have rough and irregular in shape. The Mean Median Aerodynamic Diameter (MMAD) values for milled systems decreased when compared to unmilled systems. For all physically mixed systems, the MMAD values ranges from 3.19 µm to 4.78 µm whereas the Geometric Standard Deviation (GSD) values were 1.50–2.96 µm. MMAD values for spray dried formulations ranges from 3.45 µm to 4.21 µm whereas the GSD values were 1.85–2.83 µm. These results concluded that, this novel dry powder inhaler has great potential in treatment of asthma.
Keyword: Terbutaline Sulphate, Itraconazole, Lactose, Trehalose, Physical mixing, Spray drying, Aerosol dispersion performance.
DOI: https://doi.org/10.31838/ijpr/2019.11.04.019
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free